KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Cash & Current Investments (2016 - 2026)

Edwards Lifesciences has reported Cash & Current Investments over the past 17 years, most recently at $4.2 billion for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 6.3% year-over-year to $4.2 billion; the TTM value through Dec 2025 reached $4.2 billion, up 6.3%, while the annual FY2025 figure was $4.2 billion, 6.3% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $4.2 billion at Edwards Lifesciences, up from $3.8 billion in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $4.4 billion in Q3 2024 and troughed at $512.2 million in Q4 2023.
  • A 5-year average of $2.3 billion and a median of $1.7 billion in 2022 define the central range for Cash & Current Investments.
  • Biggest five-year swings in Cash & Current Investments: plummeted 57.59% in 2023 and later soared 676.24% in 2024.
  • Year by year, Cash & Current Investments stood at $1.5 billion in 2021, then dropped by 17.66% to $1.2 billion in 2022, then plummeted by 57.59% to $512.2 million in 2023, then soared by 676.24% to $4.0 billion in 2024, then increased by 6.3% to $4.2 billion in 2025.
  • Business Quant data shows Cash & Current Investments for EW at $4.2 billion in Q4 2025, $3.8 billion in Q3 2025, and $4.1 billion in Q2 2025.